Stratus Pharmaceuticals Responds to Misinformation In the Aftermath of FDA Consent Agreement

11:15 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
In order to clarify misinformation disseminated as a result of the Consent Decree entered by the Southern District of Florida, and to which Stratus Pharmaceuticals agreed, Stratus advises that its decision to enter into that agr...

Other Sources for this Article

Carlton Fields, PA
Olga Suarez Vieira, 305-539-7379
Attorney for Stratus Pharmaceuticals


More From BioPortfolio on "Stratus Pharmaceuticals Responds to Misinformation In the Aftermath of FDA Consent Agreement"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...